Amgen

Founded in 1980, Amgen is one of the leading companies in the biotechnology industry. The company discovers, develops, manufactures and delivers human therapeutic products. It provides therapeutic services to treat a range of illnesses that includes cancers, kidney diseases and rheumatoid arthritis. Amgen also offers services to treat autoimmune diseases, such as psoriatic arthritis and ankylosing spondylitis. The company works with a team of more than 17,500 staff members. It is affiliated with Biotechnology industry Organization, Healthcare Leadership Council and Pharmaceutical Research manufacturers of America. Amgen conducts research programs related to inflammation, metabolism disorders, osteoporosis, neuroscience, oncology and hematology. Headquartered in Thousand Oaks, Calif., it maintains a location in West Greenwich, R.I.

Lyndra Therapeutics, Inc., based in Watertown, MA, is pioneering long-acting oral therapies aimed at transforming the patient experience by reducing the burden of daily medication regimens. Their innovative LYNX drug delivery platform has the potential for broad applicability across multiple therapeutic areas, including both approved and developing drugs. Generated from the website

Alnylam Pharmaceuticals is a biopharmaceutical company. The company develops novel therapeutics based on the biological breakthrough known as ribonucleic acid interference. The company applies ribonucleic acid interference to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies. This discovery enables the creation of a broad new class of human therapeutics. Alnylam Pharmaceuticals maintains partnerships with leading pharmaceutical and medical technology companies to drive further developments and capabilities. Major alliances include Merck, Medtronic and Novartis. Alnylam Pharmaceuticals, founded in 2002, maintains global headquarters in Cambridge, Mass., and has an additional operating unit in Kulmbach, Germany.